Israel Fernandez-Cadenas
Has grant
Head of the Pharmacogenomics and Genetics Group
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Israel Fernandez-Cadenas is the Head of the Pharmacogenomics and Genetics Group at the Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU) in Spain. His research focuses on the interplay between genetic factors and clinical outcomes, particularly in the context of stroke and COVID-19. Recent publications include studies on the relationship between genetic data and ischemic stroke in COVID-19 patients, as well as a review of pharmacogenetics in stroke patients treated with rtPA.
Recent Grants
Grant: Close
EPIGENESIS
Open Date: 2018-01-01
Close Date:
Grant: Close
Stroke Pharmacogenomics and Genetics
Open Date: 2018-01-01
Close Date:
Grant: Close
Epigenetics studies in stroke
Open Date: 2018-01-01
Close Date:
Grant: Close
Generación Project
Open Date: 2016-01-01
Close Date:
Grant: Close
Invictus plus
Open Date: 2016-01-01
Close Date:
Articles (2)
Year:
2021
Year:
2021
Collaborators (1)
Leonardo Bottolo
Reader of Statistics in Biomedicine
University of Cambridge
Make your next move.
Prepare your application
Review drafts before you send them.